Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis

被引:7
作者
Cheng, Wei [1 ,2 ,3 ]
Liao, Yonghui [1 ,2 ,4 ]
Xie, Yuan [1 ,2 ]
Wang, Qinrong [1 ,2 ]
Li, Leilei [1 ,2 ]
Chen, Yuanjia [1 ,2 ]
Zhao, Yan [1 ,2 ]
Zhou, Jianjiang [1 ,2 ]
机构
[1] Guizhou Med Univ, Key Lab Endem & Ethn Dis, Minist Educ, Guiyang, Peoples R China
[2] Guizhou Med Univ, Key Lab Med Mol Biol Guizhou Prov, Guiyang, Peoples R China
[3] Guizhou Med Univ, Affiliated Hosp, Dept Hematol, Guiyang, Peoples R China
[4] Qianxinan Peoples Hosp, Prenatal Diag Ctr, Xingyi, Peoples R China
基金
中国国家自然科学基金;
关键词
Serpin E1; Fibroblasts; Helicobacter pylori; p38; MAPK; Angiogenesis; PLASMINOGEN-ACTIVATOR INHIBITOR-1; EXPRESSION; PAI-1; VEGF;
D O I
10.1186/s12935-023-03177-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Fibroblasts, especially cancer-associated fibroblasts (CAFs), represent the predominant stromal cell population in the tumor microenvironment and have an important function in tumorigenesis by interacting with tumor cells. However, their interaction remains elusive in an inflammatory tumor microenvironment induced by Helicobacter pylori (H. pylori).Methods The expression of Serpin family E member 1 (Serpin E1) was measured in fibroblasts with or without H. pylori infection, and primary gastric cancer (GC) cells. Serpin E1 knockdown and overexpression fibroblasts were generated using Serpin E1 siRNA or lentivirus carrying Serpin E1. Co-culture models of fibroblasts and GC cells or human umbilical vein endothelial cells (HUVECs) were established with direct contact or the Transwell system. In vitro functional experiments and in vivo tumorigenesis assay were employed to study the malignant behaviors of GC cells interacting with fibroblasts. ELISA was used for quantifying the levels of Serpin E1 and VEGFA in the culture supernatant. The tube formation capacity of HUVECs was assessed using a tube formation assay. Recombinant human Serpin E1 (recSerpin E1), anti-Serpin E1 antibody, and a MAPK pathway inhibitor were utilized to treat HUVECs for elucidating the underlying molecular mechanisms.Results Serpin E1 was predominantly expressed in gastric CAFs. H. pylori infection significantly enhanced the expression and secretion of Serpin E1 by CAFs. Both fibroblast-derived Serpin E1 and recSerpin E1 enhanced the growth, invasion, and migration of GC cells, along with increased VEGFA expression and tube formation in HUVECs. Furthermore, the co-inoculation of GC cells and fibroblasts overexpressing Serpin E1 triggered the expression of Serpin E1 in cancer cells, which facilitated together xenograft tumor growth and peritoneal dissemination of GC cells in nude mice, with an increased expression of Ki67, Serpin E1, CD31 and/or VEGFA. These processes may be mediated by Serpin E1-induced migration and p38 MAPK/VEGFA-mediated angiogenesis of HUVECs.Conclusion H. pylori infection induces Serpin E1 expression in fibroblasts, subsequently triggering its expression in GC cells through their interaction. Serpin E1 derived from these cells promotes the migration and p38 MAPK/VEGFA-mediated angiogenesis of HUVECs, thereby facilitating GC growth and peritoneal metastasis. Targeting Serpin E1 signaling is a potential therapy strategy for H. pylori-induced GC.
引用
收藏
页数:17
相关论文
共 40 条
[1]   VEGF in Signaling and Disease: Beyond Discovery and Development [J].
Apte, Rajendra S. ;
Chen, Daniel S. ;
Ferrara, Napoleone .
CELL, 2019, 176 (06) :1248-1264
[2]   THE ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) OF HUMAN PLATELET [J].
BOOTH, NA ;
CROLL, A ;
BENNETT, B .
FIBRINOLYSIS, 1990, 4 :138-140
[3]   Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier [J].
Caron, Tyler J. ;
Scott, Kathleen E. ;
Fox, James G. ;
Hagen, Susan J. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (40) :11411-11427
[4]   Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis [J].
Chen, Xueshu ;
Chen, Wei ;
Zhao, Yan ;
Wang, Qinrong ;
Wang, Wenling ;
Xiang, Yining ;
Yuan, Hang ;
Xie, Yuan ;
Zhou, Jianjiang .
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[5]   USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis [J].
Costa, Lionel ;
Corre, Sebastien ;
Michel, Valerie ;
Le Luel, Krysten ;
Fernandes, Julien ;
Ziveri, Jason ;
Jouvion, Gregory ;
Danckaert, Anne ;
Mouchet, Nicolas ;
Barreira, David Da Silva ;
Torres, Javier ;
Camorlinga, Margarita ;
D'Elios, Mario Milco ;
Fiette, Laurence ;
De Reuse, Hilde ;
Galibert, Marie-Dominique ;
Touati, Eliette .
GUT, 2020, 69 (09) :1582-1591
[6]   Helicobacter pylori Infection [J].
Crowe, Sheila E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12) :1158-1165
[7]   Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis [J].
de Martel, Catherine ;
Georges, Damien ;
Bray, Freddie ;
Ferlay, Jacques ;
Clifford, Gary M. .
LANCET GLOBAL HEALTH, 2020, 8 (02) :E180-E190
[9]   PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells [J].
Fang, Hehui ;
Jin, Juan ;
Huang, Doudou ;
Yang, Fang ;
Guan, Xiaoxiang .
CANCER SCIENCE, 2018, 109 (06) :1949-1957
[10]   Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context [J].
Geindreau, Mannon ;
Bruchard, Melanie ;
Vegran, Frederique .
CANCERS, 2022, 14 (10)